Introduction {#s01}
============

Inclusion bodies (IBs) composed of aggregated forms of normally soluble proteins are a universal pathognomonic hallmark of neurodegenerative diseases ([@bib55]). Whether IB formation contributes to the demise of neurons in which they occur or serves as part of a cytoprotective response is controversial ([@bib1]; [@bib56]). The universal presence of 26S proteasome subunits ([@bib28]) and conjugated ubiquitin (Ub; [@bib38]; [@bib15]) within these disease-associated, intracellular aggregates has long suggested a role for disrupted protein ([@bib27]) and Ub homeostasis ([@bib5], [@bib6]; [@bib12]) as a common mechanism underlying these otherwise clinically diverse disorders. In spite of this correlation between Ub accumulation and disease pathology, a mechanistic understanding of why components of the Ub--proteasome system (UPS) machinery are sequestered at IBs and its relationship to disease etiology is still lacking.

Dominantly inherited neurodegenerative disorders, most commonly caused by mutations that result in the production of proteins with altered folding and solubility properties, have been highly informative in investigating the link between protein aggregation and Ub homeostasis ([@bib6]; [@bib2]). Genetic expansion of a CAG tract in the first exon of the huntingtin (htt) gene beyond a critical threshold of ∼35 causes Huntington's disease (HD) and results in the synthesis of a mutant htt protein containing an expanded polyglutamine (polyQ) tract ([@bib39]). Expression of exon 1 htt fragments or fusion proteins containing polyQ tracts longer than 35--40 residues leads to the formation of insoluble amyloid aggregates of htt in vitro ([@bib59]) and in cell culture ([@bib66]) and causes neurodegeneration and formation of intraneuronal IBs when expressed in the brains of transgenic ([@bib40]) or knock-in ([@bib43]) mice. Like IBs in other neurodegenerative disorders, htt IBs are robustly immunoreactive with antibodies to Ub conjugates ([@bib14]), and poly-Ub chains are significantly enriched in the brains of human HD patients and HD transgenic mice ([@bib6]), confirming that mutant htt expression is a suitable system with which to study the relationship between protein aggregation and disrupted Ub homeostasis.

Several nonmutually exclusive models have been posited to explain why Ub conjugates accumulate in IBs found in patients and models of HD and other neurodegenerative diseases. One prominent model holds that cellular "quality control" machinery recognizes mutant htt as a terminally misfolded protein ([@bib61]; [@bib9]), thereby directing the protein for destruction by the 26S proteasome. However, htt fusions with long or short polyQ tracts exhibit similarly long half-lives (\>30 h; [@bib64]; unpublished data) that are atypical of Ub-dependent proteasome system substrates. Additionally, both short and long polyQ sequences are intrinsically disordered before aggregation ([@bib67]) and are thus unlikely to adopt a conformation that is recognized as misfolded by quality control Ub ligases. Moreover, mutant htt is recruited to IBs before and independently of Ub, and only a small fraction of soluble htt is conjugated to Ub ([@bib26]). It is therefore unlikely that the majority of Ub present in IBs is conjugated to htt.

A second model posits that mutant htt interferes with the function of the 26S proteasome, causing ubiquitylated forms of many different (non-htt) proteins to accumulate and, eventually, to become sequestered in IBs. Although this model is consistent with data showing a strong correlation between mutant htt aggregation and accumulation of synthetic short-lived substrates of the UPS in cell culture ([@bib4]; [@bib5]), these UPS substrate reporters do not accumulate ([@bib8]; [@bib42]) or only accumulate transiently ([@bib49]) in mouse models of HD. In cell culture, mutant htt aggregation and recruitment of Ub conjugates to nascent IBs is not temporally correlated with accumulation of UPS reporters ([@bib26]). In vitro, purified soluble or aggregated forms of mutant htt inhibit 26S proteasome activity only when they are ubiquitylated, suggesting that they could compete with other ubiquitylated proteins for binding to Ub receptors on 26S proteasomes ([@bib5]; [@bib26]). Because htt conjugates comprise only a small fraction of soluble cellular Ub conjugates ([@bib54]), it is highly unlikely that ubiquitylated htt is present at sufficient concentrations in vivo to effectively outcompete other UPS substrates. These findings are inconsistent with a model in which mutant htt directly impairs the function of 26S proteasomes. As such, the mechanism underlying the accumulation of Ub conjugates at IBs in cells challenged with mutant htt remains unclear.

A third model to explain the accumulation of Ub conjugates in IBs after htt aggregation holds that expression of mutant, aggregation-prone proteins like htt impairs global protein homeostasis ([@bib25]; [@bib41]), possibly by sequestering one or more molecular chaperones required for the folding of chaperone-dependent clients ([@bib50]; [@bib70]). This model is supported by studies showing that expression of mutant htt causes the manifestation of multiple mutant phenotypes at permissive temperatures in *Caenorhabditis elegans* harboring temperature-sensitive alleles of unrelated genes ([@bib22]) and induces the misfolding of engineered, metastable luciferase-based "proteostasis sensors" in cultured mammalian cells ([@bib24]). The cumulative deficit caused by the challenge of mutant htt to global protein folding capacity could interfere with the folding of otherwise normal proteins, diverting misfolded proteins to the UPS and eventually exceeding the capacity of the 26S proteasome ([@bib26]). This model provides an explanation for why unrelated ubiquitylated proteins accumulate in cells challenged with aggregation-prone proteins like mutant htt, but does not explain why these Ub conjugates associate with IBs or why there is an ∼20-h delay between the onset of htt aggregation and the accumulation of synthetic fluorescent reporters of UPS activity ([@bib26]).

In this work, we have used conditionally destabilized mutants of proteins that undergo ligand-regulated misfolding and Ub-dependent degradation together with pharmacological inhibition of Ub activation to directly assess the role of Ub conjugation in recruitment of proteins to IBs. Surprisingly, our results indicate that Ub is neither necessary nor sufficient to target proteins to IBs. Instead, we find that recruitment of proteins to IBs is specified exclusively by adoption of nonnative folding states.

Results {#s02}
=======

Conditionally destabilized UPS substrates are recruited to IBs {#s03}
--------------------------------------------------------------

To assess the role of Ub conjugation in recruitment of proteins to htt IBs, we used fluorescence time-lapse microscopy to monitor the effect of mutant htt aggregation on the intracellular localization of fluorescent reporters engineered to become reversibly and conditionally misfolded by the removal of a small ligand ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201511024/DC1){#supp1}). One of these reporters, GFP-DD~FKBP~, is composed of GFP fused to a variant FK506 binding domain from FKBP12. This domain is tightly folded in the presence of the synthetic ligand shield-1 but is misfolded and efficiently targeted for Ub-dependent degradation in the absence of this ligand ([@bib3]; [@bib16]). For these experiments, we generated a stable U2OS cell line (U2-DD^FK^Q91) that expresses GFP-DD~FKBP~ constitutively and mutant htt exon 1 fused to mCherry fluorescent protein (httQ91-mCherry) under the control of a tetracycline-inducible (TET-ON) promoter. Addition of shield-1 to these cells in the absence of doxycycline (dox) caused a uniform ∼10-fold increase in the mean GFP fluorescence of the population ([Fig. 1, A and C](#fig1){ref-type="fig"}, top). This fluorescence was distributed diffusely in the nuclear and cytoplasmic compartments ([Fig. 1 A](#fig1){ref-type="fig"}). After washout of shield-1, GFP-DD~FKBP~ fluorescence levels decayed to baseline ([Fig. 1, A and B](#fig1){ref-type="fig"}; and Fig. S1 B). This decay (t~1/2~ of ∼90 min) was abrogated by addition of an inhibitor of the Ub-activating enzyme E1 (E1 inhibitor; [Fig. 1 B](#fig1){ref-type="fig"}) at concentrations sufficient to inhibit Ub conjugation, as assessed by the rapid depletion of ubiquitylated proteins (Fig. S1 C; [@bib11]). These results confirm that in U2-DD^FK^Q91 cells, GFP-DD~FKBP~ is rapidly degraded in a Ub-dependent manner upon withdrawal of shield-1 ([@bib16]).

![**Conditionally destabilized reporters are recruited to IBs.** (A) GFP-DD~FKBP~ is stabilized by shield-1. U2OS cells stably expressing GFP-DD~FKBP~ and tetracycline-inducible httQ91-mCherry (U2-DD^FK^Q91) were treated with 1 µM shield-1 or subjected to shield-1 washout and imaged by time-lapse microscopy. (B) GFP-DD~FKBP~ undergoes Ub-dependent degradation. GFP-DD~FKBP~ fluorescence in U2-DD^FK^Q91 cells was determined by flow cytometry analysis in the presence of 1 µM shield-1 (S1) or after washout of shield-1 for 6 h in the presence or absence of 10 µM E1 inhibitor. (C) U2-DD^FK^Q91 cells were treated with 1 µM shield-1 (top) or 1 µg/ml dox (bottom) for 72 h and analyzed by flow cytometry. (D--F) Misfolded but not folded GFP-DD~FKBP~ is recruited to httQ91-mCherry IBs. U2-DD^FK^Q91 cells were treated with 1 µg/ml dox for 48 h and imaged by time-lapse microscopy in the absence of shield-1 (D), in the presence of 1 µM shield-1 (E), or after shield-1 washout (F). (G) Cells stably expressing DD~DHFR~-GFP and tetracycline-inducible httQ91-mCherry (U2-DD^DH^Q91) were treated with 10 µM TMP (top) or 1 µg/ml dox (bottom) for 72 h and analyzed by flow cytometry. (H and I) Misfolded but not folded DD~DHFR~-GFP is recruited to httQ91-mCherry IBs. U2-DD^DH^Q91 cells were treated with 1 µg/ml dox for 48 h and imaged by time-lapse microscopy in the presence of 10 µM TMP (H) or after TMP washout (I). Time stamps indicate elapsed time in minutes. For montages of httQ91-mCherry, t = 0 min indicates the frame in which IBs were first observed, and negative values correspond to time in minutes preceding this frame. (A, D--F, H, and I) Microscopy panels are representative of *n* \> 50 (A and D--F) and *n* \> 10 (H and I) independent observations. Arrowheads indicate IBs. (B, C, and G) For flow cytometry, *n* \> 10,000 cells were analyzed. Ctl, control. Bars, 10 µm.](JCB_201511024_Fig1){#fig1}

To assess the effect of IB formation on GFP-DD~FKBP~, we induced expression of httQ91-mCherry in U2-DD^FK^Q91 cells. Addition of dox resulted in increased httQ91-mCherry fluorescence intensity ([Fig. 1 C](#fig1){ref-type="fig"}, bottom; and Fig. S1 D) and a time-dependent increase in the fraction of cells with IBs, which reached a plateau by 72 h (Fig. S1 E). Time-lapse video microscopy of these cells revealed that, as previously observed ([@bib26]), httQ91-mCherry redistributed from an initially diffuse cytoplasmic localization to a single, centrally located IB once its levels exceeded a critical concentration ([Fig. 1 D](#fig1){ref-type="fig"}). Although there was some cell-to-cell variability in the time course, aggregation of httQ91-mCherry occurred rapidly, with httQ91-mCherry fluorescence at IBs reaching a plateau within 100 min (Fig. S1 F). This behavior is consistent with previous studies demonstrating that mutant htt IBs nucleate the efficient and rapid recruitment of soluble htt monomers into amyloid aggregates ([@bib58], [@bib59]). GFP-DD~FKBP~ fluorescence was excluded from IBs when httQ91-mCherry expression was induced in the presence of shield-1--stabilized GFP-DD~FKBP~ ([Fig. 1 E](#fig1){ref-type="fig"}). In contrast, GFP-DD~FKBP~ fluorescence accumulated at nascent IBs in the absence of shield-1 ([Fig. 1 D](#fig1){ref-type="fig"} and Fig. S1 F) or after washout of shield-1 ([Fig. 1 F](#fig1){ref-type="fig"}). GFP-DD~FKBP~ maintained a cytoplasmic/nuclear distribution in cells expressing diffuse httQ91-mCherry ([Fig. 1, D and F](#fig1){ref-type="fig"}). Thus, recruitment of GFP-DD~FKBP~ is exclusively a property of misfolded, UPS-targeted conformers of GFP-DD~FKBP~.

The recruitment of misfolded conformers of GFP-DD~FKBP~ to IBs led us to ask whether this property is common to misfolded conformers of other conditionally destabilized proteins. One such protein, DD~DHFR~-GFP, is a fluorescent reporter consisting of bacterial dihydrofolate reductase engineered to undergo degradation by the UPS when expressed in the absence of the folate analogue trimethoprim (TMP; [@bib29]). We generated a stable U2OS line (U2-DD^DH^Q91) that expresses DD~DHFR~-GFP constitutively and TET-ON httQ91-mCherry. In the absence of TMP and dox, basal GFP fluorescence in these cells was not detectable above background ([Fig. 1 G](#fig1){ref-type="fig"}), consistent with the very short half-life (t~1/2~ of ∼30 min) of this reporter (Fig. S1 H). DD~DHFR~-GFP fluorescence increased dramatically after exposure of U2-DD^DH^Q91 cells to TMP ([Fig. 1 G](#fig1){ref-type="fig"}) and decayed rapidly after TMP washout (Fig. S1 B). This decay was blocked by the E1 inhibitor (Fig. S1 G), indicating that, like GFP-DD~FKBP~, turnover of DD~DHFR~-GFP is dependent on Ub conjugation. Time-lapse imaging revealed that, as with GFP-DD~FKBP~, folded DD~DHFR~-GFP (i.e., in the presence of TMP) was excluded from IBs ([Fig. 1 H](#fig1){ref-type="fig"}), whereas washout of TMP led to sequestration of DD~DHFR~-GFP in mCherry-positive IBs ([Fig. 1 I](#fig1){ref-type="fig"}). The kinetics of DD~DHFR~-GFP recruitment to IBs were considerably slower than those exhibited by GFP-DD~FKBP~, likely reflecting the intrinsically faster turnover of DD~DHFR~-GFP (Fig. S1 H). These data show that the ability to be recruited to htt IBs in the absence of ligands is a common property of two structurally unrelated protein reporters containing unrelated conditional degrons. In the absence of the ligand, both proteins adopt nonnative (misfolded) states that are targeted for Ub-dependent conjugation and destruction by the 26S proteasome. Thus, recruitment to IBs could be a consequence of the (mis)folding state, Ub conjugation, or both.

Ub conjugation is neither necessary nor sufficient for recruitment of misfolded GFP-DD~FKBP~ to IBs {#s04}
---------------------------------------------------------------------------------------------------

To determine whether conjugation to Ub is sufficient to recruit GFP-DD~FKBP~ to IBs, we developed a reporter, Ub^G76V^-Venus-DD~FKBP~, containing a noncleavable Ub (Ub^G76V^) fused to the N terminus of Venus-DD~FKBP~ that, despite being tightly folded in the presence of shield-1, is constitutively ubiquitylated and degraded by the proteasome. N-terminal Ub^G76V^ cannot be removed by Ub-specific proteases and functions as a dominant degron that can target even correctly folded, long-lived proteins for polyubiquitylation and degradation by the UPS ([@bib31]; [@bib13]). Fluorescence time-lapse imaging of cells expressing Ub^G76V^-Venus-DD~FKBP~ after translation shutoff showed that this reporter is indeed rapidly degraded (t~1/2~ of ∼90 min), even in the presence of shield-1 ([Fig. 2 A](#fig2){ref-type="fig"} and [Fig. S2, A and B](http://www.jcb.org/cgi/content/full/jcb.201511024/DC1){#supp2}). This degradation was completely blocked by the E1 inhibitor (Fig. S2 B). In contrast, an identical construct lacking the N-terminal Ub^G76V^ was extremely stable in the presence of shield-1 (t~1/2~ \> 12 h; [Fig. 2 A](#fig2){ref-type="fig"}) and was degraded more slowly than Ub^G76V^-Venus-DD~FKBP~ in the absence of shield-1 (Fig. S2 B), indicating that Ub^G76V^ fusion functions as a dominant Ub-dependent degron, even in the presence of a stabilizing ligand. Consistent with its rapid Ub-dependent turnover, ubiquitylated forms of Ub^G76V^-Venus-DD~FKBP~ were detected ([Fig. 2 B](#fig2){ref-type="fig"}) after affinity capture of Ub conjugates by the Ub-associated (UBA) domain of hPLIC-2 (UBA~hPLIC-2~; [@bib52]). Thus, the Ub^G76V^ fusion promotes constitutive ubiquitylation and degradation of folded, shield-1--bound Ub^G76V^-Venus-DD~FKBP~.

![**Ub conjugation is not necessary or sufficient for recruitment of GFP-DD~FKBP~ to IBs.** (A) Fusion to Ub^G76V^ decreases the half-life of folded Venus-DD~FKBP~. Cells were transiently transfected with Ub^G76V^-Venus-DD~FKBP~ or Venus-DD~FKBP~ for 48 h in the presence of 1 µM shield-1, and mean Venus fluorescence of cells (*n* \> 10) was determined by time-lapse microscopy after translation shutoff with 25 µM emetine. (B) Folded Ub^G76V^-Venus-DD~FKBP~ is constitutively ubiquitylated. Cells were transiently transfected with GFP-DD~FKBP~ or Ub^G76V^-Venus-DD~FKBP~ in the presence of 1 µM shield-1 or vehicle for 72 h. Subsequently, Ub conjugates were affinity captured by incubating cell lysates with UBA~hplic-2~-conjugated beads, and eluate and unbound fractions were analyzed by SDS-PAGE and immunoblotting with anti-GFP and anti-Ub antibodies. (C) Folded and ubiquitylated Ub^G76V^-Venus-DD~FKBP~ is not recruited to IBs. Cells transiently transfected with httQ91-mCherry and Ub^G76V^-Venus-DD~FKBP~ for 48 h in the presence of 1 µM shield-1 were imaged by time-lapse microscopy. (D) E1 inhibitor blocks degradation of misfolded GFP-DD~FKBP~. U2-DD^FK^Q91 cells were treated with 1 µg/ml dox and 1 µM shield-1 for 48 h. Mean GFP-DD~FKBP~ fluorescence of cells (*n* \> 10) was determined by time-lapse microscopy after shield-1 washout in the presence or absence of 10 µM E1 inhibitor. (E) E1 inhibitor blocks ubiquitylation of misfolded GFP-DD~FKBP~. U2-DD^FK^Q91 cells incubated with 1 µM shield-1 were treated for 3 h with 10 µM E1 inhibitor or vehicle. After a 15-min shield-1 washout, Ub conjugates were affinity captured from cell lysates with UBA~hplic-2~ beads and eluate, and unbound fractions were analyzed by SDS-PAGE and immunoblotting with anti-GFP antibody. (F) Misfolded, nonubiquitylated GFP-DD~FKBP~ is recruited to IBs. U2-DD^FK^Q91 cells were treated for 48 h with 1 µM shield-1 and 1 µg/ml dox. Cells were subsequently treated for 3 h with 10 µM E1 inhibitor, subjected to shield-1 washout, and imaged by time-lapse microscopy. (G) E1 inhibitor does not block recruitment of GFP-DD~FKBP~ to IBs. GFP-DD~FKBP~ fluorescence at IBs was measured in cells (*n* \> 10) after shield-1 washout in the presence or absence of 10 µM E1 inhibitor. IB start indicates the frame in which httQ91-mCherry IBs were first detected. Time stamps indicate elapsed time in minutes. For C and F, t = 0 indicates the frame in which IBs were first observed, and negative values correspond to time in minutes preceding this frame. Data points indicate mean ± SD. Microscopy panels C and F are representative of *n* \> 20 independent observations. Bars, 10 µm. Arrowheads indicate IBs. Western blots (WBs) are representative experiments from at least two independent repeats. Statistically relevant differences (α = 0.05): \*\*, P \< 0.0001.](JCB_201511024_Fig2){#fig2}

Time-lapse microscopy imaging revealed that Ub^G76V^-Venus-DD~FKBP~ was recruited to IBs in the absence of shield-1 (Fig. S2 C), indicating that the Ub^G76V^ fusion does not interfere with the sequestration of misfolded Ub^G76V^-Venus-DD~FKBP~. In contrast, addition of shield-1 completely prevented Ub^G76V^-Venus-DD~FKBP~ recruitment to IBs ([Fig. 2 C](#fig2){ref-type="fig"}). These results demonstrate that Ub conjugation is not sufficient to recruit folded UPS substrates such as Ub^G76V^-Venus-DD~FKBP~ to IBs but do not rule out the possibility that Ub functions as an essential IB targeting signal for misfolded proteins.

To determine whether Ub conjugation is necessary for IB recruitment, we used the E1 inhibitor to block conjugation of Ub to misfolded GFP-DD~FKBP~. Before adding E1 inhibitor, cells expressing this reporter were incubated with shield-1 overnight to allow folded GFP-DD~FKBP~ to accumulate. Upon washout of shield-1, GFP-DD~FKBP~ fluorescence declined rapidly ([Fig. 2 D](#fig2){ref-type="fig"}), and high molecular weight forms of GFP-DD~FKBP~ were detected after affinity capture by UBA~hPLIC-2~ beads ([Fig. 2 E](#fig2){ref-type="fig"}). In contrast, when shield-1 was washed out in the presence of E1 inhibitor, GFP-DD~FKBP~ was markedly stabilized ([Fig. 2 D](#fig2){ref-type="fig"} and Fig. S2 D), and ubiquitylated forms of the reporter were not captured by UBA~hPLIC-2~ beads ([Fig. 2 E](#fig2){ref-type="fig"}). Therefore, the combination of shield-1 washout and E1 inhibitor can be used to acutely generate a cohort of misfolded, nonubiquitylated GFP-DD~FKBP~ molecules. These conditions (shield-1 washout with E1 inhibitor) did not impede recruitment of httQ91-mCherry to IBs (Fig. S2 E), confirming that Ub conjugation is not required for IB formation. Strikingly, recruitment of misfolded GFP-DD~FKBP~ to IBs after shield-1 washout occurred with similar kinetics irrespective of the presence of the E1 inhibitor ([Fig. 2, F and G](#fig2){ref-type="fig"}). Thus, Ub conjugation is neither necessary nor sufficient for recruitment of GFP-DD~FKBP~ to IBs. Together, these data suggest that the folding state, but not the ubiquitylation state, is the primary determinant of recruitment of proteins to IBs.

Misfolded GFP-DD~FKBP~ and Ub conjugates are stabilized at IBs {#s05}
--------------------------------------------------------------

It has previously been proposed that targeting of Ub conjugates to IBs facilitates degradation of misfolded, ubiquitylated proteins via autophagy ([@bib33]; [@bib46]; [@bib36]). However, we found that GFP-DD~FKBP~ fluorescence at IBs after shield-1 washout was extremely stable (t~1/2~ \> 16 h; [Fig. 3, A and B](#fig3){ref-type="fig"}). In contrast, GFP-DD~FKBP~ fluorescence in cytosolic regions adjacent to IBs, or in the cytosol of cells that have only diffuse httQ91-mCherry fluorescence, decayed rapidly (t~1/2~ of ∼150 min) upon shield-1 washout ([Fig. 3 B](#fig3){ref-type="fig"}). The rate of decay was similar to the decay kinetics of this reporter in the absence of shield-1 in cells not expressing htt (Fig. S1 B). These data suggest that stabilization of GFP-DD~FKBP~ fluorescence at IBs is not a consequence of global impairment of protein turnover by htt IBs. Acute addition of shield-1 to dox-induced U2-DD^FK^Q91 cells led to stabilization of cytoplasmic GFP-DD~FKBP~ but did not lead to decreased GFP-DD~FKBP~ fluorescence within IBs that were present before addition of the stabilizing ligand ([Fig. 3, C and D](#fig3){ref-type="fig"}; and [Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201511024/DC1){#supp3}). Thus, misfolded GFP-DD~FKBP~ at IBs is stable and refractory to folding by shield-1.

![**Misfolded GFP-DD~FKBP~ and Ub conjugates are stable at IBs.** (A) Misfolded GFP-DD~FKBP~ is stable at IBs. U2-DD^FK^Q91 cells were treated with 1 µg/ml dox and 1 µM shield-1 for 48 h and imaged by time-lapse microscopy after washout of shield-1. (B) Quantification of mean GFP-DD~FKBP~ fluorescence at IBs in the cytosol/nucleus of cells with IBs present and in the cytosol/nucleus of cells without IBs in cells (*n* \> 10) imaged in A. (C) Misfolded GFP-DD~FKBP~ is sequestered at IBs. U2-DD^FK^Q91 cells were treated with 1 µg/ml dox for 48 h. Cells were subsequently imaged by time-lapse microscopy after addition of 1 µM shield-1 and 25 µM emetine to prevent accumulation of cytosolic and nuclear GFP-DD~FKBP~ fluorescence (for addition of emetine only; [Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201511024/DC1){#supp4}). Arrowheads indicate IBs that formed after addition of shield-1, and arrows indicate IBs that were present before addition of shield-1. (D) Quantification of mean GFP-DD~FKBP~ fluorescence at IBs and in the cytosol/nucleus in cells (*n* \> 10) imaged in C. (E) YFP-Ub accumulates at IBs. U2-Ub-Q91 cells were treated with 1 µg/ml dox for 48 h and imaged by time-lapse microscopy. (F) Quantification of YFP-Ub and httQ91-mCherry fluorescence at IBs in cells (*n* \> 10) imaged in E. IB start indicates the frame in which httQ91-mCherry IBs were first detected. (G) Ub conjugates are stable at IBs. U2-Ub-Q91 cells were treated with 1 µg/ml dox for 48 h. Cells were subsequently treated for 3 h with 10 µM E1 inhibitor and imaged by time-lapse microscopy. (H) Quantification of YFP-Ub fluorescence at IBs in cells (*n* \> 15) imaged in G. Arrowheads indicate IBs in A, E, and G. Time stamps indicate elapsed time in minutes. Bars, 10 µm. Data points indicate mean ± SD. Statistically relevant differences (α = 0.05): \*\*, P \< 0.0001.](JCB_201511024_Fig3){#fig3}

To test whether stabilization at IBs is unique to misfolded GFP-fusion reporters like GFP-DD~FKBP~ or DD~DHFR~-GFP or is a general property of Ub conjugates recruited to these sites, we monitored partitioning of conjugated Ub to IBs with Ub fused to YFP (YFP-Ub; [@bib51]) in stable U2OS cells that express YFP-Ub constitutively and httQ91-mCherry under the control of a TET-ON promoter (U2-Ub-Q91; Fig. S3 B). YFP-Ub was recruited to IBs in these cells after a variable (∼10--50 min) time lag ([Fig. 3, E and F](#fig3){ref-type="fig"}; and Fig. S3, C and D), consistent with our previous observation in transiently transfected U2OS cells ([@bib26]). A conjugation-defective YFP-Ub variant containing a glycine to alanine mutation at the C terminus (YFP-Ub^G76A^) was not recruited to IBs (Fig. S3 E), indicating that recruitment of Ub to IBs requires its covalent conjugation to proteins.

We assessed the stability of Ub conjugates at IBs under conditions where Ub conjugation was globally inhibited by the E1 inhibitor. Despite a significant reduction in levels of total Ub conjugates observed after a 3-h treatment with E1 inhibitor (Fig. S1 C), YFP-Ub fluorescence at IBs remained stable for \>5 h ([Fig. 3, G and H](#fig3){ref-type="fig"}). Moreover, analysis of YFP-Ub mobility at IBs by FRAP indicated that YFP-Ub did not exchange between IBs and the cytosol (Fig. S3 F). These data indicate that Ub conjugates, like misfolded DD reporters, are stably associated with IBs.

Misfolded firefly luciferase (Fluc)--GFP is recruited to IBs {#s06}
------------------------------------------------------------

Unlike engineered degradation domains (DDs), which can be switched between homogenous folded and misfolded states, most proteins exist in a dynamic equilibrium between a single, folded native conformation and an ensemble of partially folded conformers, reflecting either the kinetics of folding to or partial unfolding from the native state ([@bib27]). To study the partitioning of metastable proteins between the cytosol and IBs, we exploited a conformationally destabilized variant of Fluc (smFluc-GFP), a metastable protein engineered to have a steep dependence on cytoplasmic chaperones to remain folded, active, and soluble ([@bib24]). smFluc-GFP has been previously shown to aggregate and colocalize with IBs in HEK293 cells expressing mutant htt ([@bib24]). We found that in cells coexpressing httQ91-mCherry, smFluc-GFP became associated with the IB after a variable delay of 1--2 h ([Fig. 4 A](#fig4){ref-type="fig"}, arrowheads). It is probable that this delay underlies the more peripheral association of smFluc-GFP compared with GFP-DD~FKBP~, which was recruited to httQ91-mCherry foci more rapidly (Fig. S1 F). In contrast to the DD reporters, recruitment of smFluc-GFP to IBs was temporally accompanied by the appearance of multiple GFP foci ([Fig. 4 A](#fig4){ref-type="fig"}, arrows) that were distinct from and not associated with IBs or mCherry puncta. The appearance of these non-IB--associated smFluc-GFP foci usually followed the emergence of httQ91-mCherry IBs ([Fig. S4 A](http://www.jcb.org/cgi/content/full/jcb.201511024/DC1){#supp5}). We also observed that wild-type (wt) Fluc-GFP (wtFluc-GFP) was recruited to both IB-associated and peripheral foci with kinetics similar to those observed for smFluc-GFP ([Fig. 4 B](#fig4){ref-type="fig"}), suggesting that the equilibrium between folded and partially folded states (i.e., the intracellular protein folding environment) can be altered by a process temporally associated with the solubility transition of httQ91-mCherry. httQ91-mCherry may induce wtFluc-GFP misfolding/aggregation by sequestering chaperones essential for wtFluc-GFP folding ([@bib18]), some of which could function to suppress mutant htt aggregation. If true, we reasoned that expression of wtFluc-GFP or misfolded chaperone clients such as DD reporters should increase the propensity of httQ91-mCherry to aggregate by competing with htt for this limited pool of chaperones. To test this model, we used pulse-shape analysis (PulSA; [@bib53]) to generate IB dose--response profiles ([@bib7]; [@bib48]) that report the critical concentration at which httQ91-mCherry forms IBs (Fig. S4 B) in cells expressing low or high levels of GFP-DD~FKBP~ and DD~DHFR~-GFP reporters (Fig. S4 E). The httQ91-mCherry IB dose--response profiles for cells expressing GFP-DD~FKBP~ or DD~DHFR~-GFP shifted to the left when the ligands shield-1 or TMP, respectively, were absent, indicating that expression of these misfolded proteins caused IBs to form at a lower total httQ91-mCherry concentration ([Fig. 4, C and D](#fig4){ref-type="fig"}). This shift was more pronounced in cells expressing high levels of the reporters ([Fig. 4, C and D](#fig4){ref-type="fig"}). Addition of shield-1 (Fig. S4 C) or TMP (Fig. S4 D) did not alter the dose--response profile of httQ91-mCherry aggregation in the absence of the ligand-binding reporters. Thus, expression of misfolded proteins decreases the concentration at which httQ91-mCherry transitions into IBs in a dose-dependent manner. These data support a model whereby misfolded proteins and httQ91-mCherry compete with each other for access to cellular factors that maintain their respective solubility. A similar effect on httQ91-mCherry IB formation was observed in cells expressing high levels of wtFluc-GFP, a metastable protein, but not stably folded GFP ([Fig. 4 E](#fig4){ref-type="fig"}). Together, these data suggest that metastable and conformationally challenged proteins alter the cytoplasmic milieu to reduce the critical concentration at which httQ91-mCherry aggregates.

![**Misfolded Fluc-GFP is recruited to IBs.** (A and B) smFluc-GFP and wtFluc-GFP are recruited to IBs and distinct foci. Cells were transiently transfected with htt91-mCherry and smFluc-GFP (A) or wtFluc-GFP (B) for 48 h and imaged by time-lapse microscopy. Arrowheads indicate IBs, and arrows indicate Fluc-GFP foci that do not colocalize with IBs. Time stamps indicate elapsed time in minutes. t = 0 min indicates the frame in which IBs were first observed, and negative values correspond to time in minutes preceding this frame. Bars, 10 µm. (C) GFP-DD~FKBP~ decreases the concentration at which httQ91-mCherry forms IBs. Cells stably expressing tetracycline-inducible httQ91-mCherry (U2-Q91) were transiently transfected with GFP-DD~FKBP~ in the presence of vehicle or 1 µM shield-1 for 24 h. After addition of 1 µg/ml dox for 72 h, cells expressing low or high levels of GFP-DD~FKBP~ were analyzed by PulSA. (D) DD~DHFR~-GFP decreases the concentration at which httQ91-mCherry forms IBs. U2-Q91 were transiently transfected with DD~DHFR~-GFP in the presence of vehicle or 10 µM TMP for 24 h. After addition of 1 µg/ml dox for 72 h, cells expressing low or high levels of DD~DHFR~-GFP were analyzed by PulSA. (E) wtFluc-GFP decreases the concentration at which httQ91-mCherry forms IBs. U2-Q91 were transiently transfected with GFP or wtFluc-GFP for 24 h. After addition of 1 µg/ml dox for 72 h, cells expressing low or high levels of wtFluc-GFP or GFP were analyzed by PulSA. Microscopy in A is representative of *n* \> 10, and B is representative of *n* \> 20 independent observations. Flow cytometry in C--E are representative experiments of at least two independent repeats.](JCB_201511024_Fig4){#fig4}

Discussion {#s07}
==========

The ubiquity of Ub conjugates at intracellular IBs has long suggested a link between protein aggregation and disrupted protein homeostasis, but an understanding of their biological significance and the specific mechanisms by which these Ub conjugates are formed and recruited to IBs has remained obscure. The prevailing model---that most Ub is conjugated to the principal aggregated components of IBs, e.g., α-synuclein in Lewy bodies ([@bib63]) or htt in HD IBs ([@bib61]), and contributes to sequestration of these proteins ([@bib37]; [@bib33]; [@bib30])---is inconsistent with evidence that these proteins, which are typically mostly or entirely intrinsically disordered, are poor substrates for Ub conjugation and turnover ([@bib17]; [@bib67]). This conclusion is also supported by time-lapse studies in human cells showing that Ub arrives at IBs after deposition of mutant htt ([@bib26]), histological studies of IBs in human and mouse brains showing that not all IBs contain Ub ([@bib57]; [@bib23]), Ub-independent targeting of quality control substrates to nuclear IBs in yeast ([@bib44]), and recruitment of a nonubiquitylated, misfolded reporter GFP-250 to IBs ([@bib21]). The data reported here establish that Ub is neither necessary nor sufficient to direct proteins to IBs. However, because Ub^G76V^ fusions predominantly undergo ubiquitylation by K48- and K29-linked chains ([@bib35]), we do not exclude the possibility that other Ub chain linkages are sufficient to target proteins to IBs. K63-linked ubiquitylation by the E3 Ub ligase parkin has been reported to target the Parkinson's disease--associated protein DJ-1 to IBs ([@bib47]), and K63-linked chains have been reported to promote IB formation by mutant tau and SOD1 ([@bib62]).

Here, we use two different models of ligand-dependent, conditional misfolding to show that folding state is the key determinant of protein recruitment to cytoplasmic, polyQ IBs. We find that two structurally unrelated proteins, mutant DHFR and FK506-binding domain, are recruited to htt IBs only when they are conformationally destabilized by removal of high affinity small molecule ligands. Although these proteins in their unliganded state are ubiquitylated and normally targeted for destruction by the 26S proteasome, our data show that they become diverted to htt IBs where they are protected from degradation. Surprisingly, we find that Ub conjugation is neither necessary nor sufficient for this recruitment. We propose a model in which protein aggregation disrupts intracellular protein homeostasis by competing for limiting chaperones and protein folding machinery and whereby protein aggregates divert misfolded or partially folded proteins away from the proteasome to IBs. The stabilization of Ub conjugates at IBs may explain why Ub chains accumulate in brain tissues from HD patients ([@bib6]).

The finding that IB-associated Ub conjugates are refractory to proteasomal degradation is surprising given evidence that proteasomes remain proteolytically active at IBs ([@bib68]; [@bib60]). It is likely that 26S proteasomes are recruited to IBs by the poly-Ub chains on the IB surface. One possibility is that misfolded, polyubiquitylated proteins at IBs are bound by the 19S cap of the proteasome but are not efficiently unfolded and therefore not subject to proteolysis. This may be caused by incorporation of ubiquitylated proteins into highly stable polyQ aggregates, as was previously demonstrated for short polyQ sequences bearing degradation signals recruited to IBs composed of ataxin-1 containing an expanded polyQ stretch ([@bib65]). Previous studies have suggested that IBs can be cleared by basal ([@bib30]; [@bib10]) or pharmacologically induced ([@bib10]) macroautophagy and that Ub conjugation may signal autophagic clearance of proteins at IBs ([@bib69]). We did not observe clearance of IBs or Ub conjugates at IBs in time-lapse microcopy experiments, even after transcriptional shutoff of httQ91-mCherry expression (unpublished data). IB turnover was also not observed in a study in which individual striatal neurons expressing mutant htt were imaged over several days, despite evidence that these neurons up-regulated autophagy pathways ([@bib64]). Our data suggest that htt IBs do not function as sites of proteolysis but leave open the possibility that IBs composed of other aggregation-prone proteins are cleared by autophagy.

Our data supports a model in which mutant htt expression increases the likelihood that proteins adopt misfolded conformations by disrupting the protein folding environment. Indeed, we observed that recruitment of wtFluc-GFP and smFluc-GFP to IBs coincided with the appearance of Fluc-GFP aggregates, suggesting that the Fluc-GFP folding equilibrium is compromised by httQ91 aggregation. Titration of chaperones by IBs is one mechanism by which mutant htt may disrupt Fluc-GFP folding. A recent study suggested that sequestration of Hsc70 by IBs leads to defects in endocytosis by preventing Hsc70-mediated uncoating of clathrin-coated vesicles ([@bib70]). Another study in a yeast polyQ model proposed that sequestration of the chaperone Sis1p at IBs inhibits shuttling of a proteasome substrate to the nucleus for degradation ([@bib50]). Although these studies suggest that mutant htt in IBs is the "toxic species" that disrupts protein homeostasis, we find that expression of wtFluc-GFP decreases the concentration at which diffuse httQ91 transitions into IBs, suggesting that soluble htt competes with wtFluc-GFP, and potentially other chaperone clients, for folding machinery. This conclusion is consistent with studies showing that worms harboring temperature-sensitive mutations exhibit an earlier appearance of polyQ aggregates ([@bib22]).

Our results establish that a misfolded conformation is sufficient to target proteins to polyQ IBs. Disruption of microtubules with nocodazole did not block recruitment of GFP-DD~FKBP~ to IBs (unpublished data), indicating that this reporter, unlike some aggregation-prone proteins ([@bib32]), is not recruited to IBs through microtubule-directed transport. Interestingly, misfolded conformers of GFP-DD~FKBP~ and DD~DHFR~-GFP were recruited to IBs with very different kinetics. These results may be explained by the more rapid turnover of DD~DHFR~-GFP. Another possibility is that GFP-DD~FKBP~ and DD~DHFR~-GFP sample different unfolded or misfolded conformations or contain partially folded domains that differentially promote IB recruitment. The glutamine/asparagine (Q/N)-rich domains of the RNA-binding proteins TDP-43 ([@bib19]) and TIA-1 ([@bib20]) are sufficient to recruit these proteins to IBs, and htt aggregates can seed the aggregation of the Q/N-rich domain of TIA-1 in vitro ([@bib20]; [@bib34]). Our data suggest that although inhibition of protein quality control with the E1 inhibitor affects GFP-DD~FKBP~ solubility and clearance (Fig. S2 D), mutant htt IBs do not inhibit degradation or promote the aggregation of GFP-DD~FKBP~ not associated with IBs. These findings suggest that, in addition to titrating one or more limiting components of the protein folding machinery, IBs could recruit constitutively misfolded GFP-DD~FKBP~ independently of disrupting protein homeostasis. Although considerably less efficient than homotypic seeding, heterotypic seeding has been shown to occur in vitro and in vivo and has been proposed to contribute to cooperative interactions between protein aggregates in diseases of protein misfolding ([@bib45]). Cross-seeding may trap GFP-DD~FKBP~ within IBs and may explain why GFP-DD~FKBP~ is an integral component of IBs and why it is refractory to proteasome-mediated degradation. In contrast, Fluc-GFP is only recruited to the IB periphery after a significant lag time, perhaps reflecting the time required for misfolded forms of the protein to accumulate. However, we consider it equally possible that interaction of GFP-DD~FKBP~ with IBs could be bridged by as yet unidentified proteins or chaperones. Additional studies are needed in order to elucidate the mechanism by which proteins that adopt misfolded conformations are targeted to IBs.

Materials and methods {#s08}
=====================

Plasmids {#s09}
--------

httQ91-mCherry encodes mCherry fused to the N terminus of htt exon 1 as described previously ([@bib26]). Tetracycline-inducible httQ91-mCherry was generated by inserting httQ91-mCherry into the KpnI site in pTRE-Tight (Takara Bio Inc.). GFP-DD~FKBP~ and Venus-DD~FKBP~ encode GFP or Venus, respectively, that were fused to the N terminus of mutant FKBP12 (F36V, E31G, R71G, and K105E; a gift from T. Wandless, Stanford University, Stanford, CA) and inserted into BamHI and XhoI sites in pcDNA3.1. DD~DHFR~-GFP encodes GFP that was fused to the C terminus of mutant *Escherichia coli* dihydrofolate reductase (R12Y, G67S, and Y100I; a gift from T. Wandless) and inserted into BamHI and NotI sites in pcDNA3.1. Ub^G76V^-Venus-DD~FKBP~ was created by inserting Ub^G76V^ between NheI and KpnI sites in Venus-DD~FKBP~. wtFluc-GFP and smFluc-GFP (a gift from U. Hartl, Max Planck Institute of Biochemistry, Munich, Germany) were described previously ([@bib24]).

Cell lines {#s10}
----------

U2OS cells expressing tetracycline-inducible httQ91-mCherry (U2-Q91) were generated by cotransfection of U2OS TET-ON (Takara Bio Inc.) cells with pTRE-Tight httQ91-mCherry and linear puromycin marker (Takara Bio Inc.) in a 20:1 weight/weight ratio for 72 h, selection in media containing 1 µg/ml puromycin, and cloning by limited dilution. The clonal line exhibiting the highest httQ91-mCherry fluorescence in the presence of dox was cotransfected with pTRE-Tight and pcDNA3.1/Hygro in a 20:1 weight/weight ratio for 72 h and selected in media containing 500 µg/ml hygromycin, and clonal lines exhibiting the highest httQ91-mCherry fluorescence were isolated by limited dilution cloning. GFP-DD~FKBP~ and DD~DHFR~-GFP lines U2-DD^FK^Q91 and U2-DD^DH^Q91, respectively, were generated by transfection of U2-Q91 cells with these plasmids and selection in 400 µg/ml Zeocin followed by cloning by limited dilution.

Microscopy {#s11}
----------

For live cell time-lapse microscopy, U2OS cells were seeded in glass-bottom 4-well imaging chambers (Lab-Tek II; Thermo Fisher Scientific) in DMEM with 10% FBS. Cells were transfected the following day with FuGENE 6 (Roche) according to the manufacturer's instructions and imaged after 48 h. For induction of expression in TET-ON cells stably expressing httQ91-mCherry, cells were treated with 1 µg/ml dox for 48 h before imaging. Imaging was performed on an inverted microscope (Axiovert 200M; ZEISS) encased in a chamber (Perspex) heated to 37°C and continuously perfused with humidified 5% CO~2~. Digital 12-bit images were acquired at multiple stage positions using a cooled charge-coupled device camera (CoolSNAP HQ; Photometrics) with an exacte light source (X-Cite; Lumen Dynamics), filter cubes for visualizing mCherry, YFP, or GFP (Chroma Technology Corp.), and a 40× air objective. MetaMorph software (Molecular Devices) was used to control the microscope, and ImageJ (National Institutes of Health) was used for image processing and quantification of fluorescence intensity.

For shield-1 and TMP washout experiments, cells were washed three times with PBS, and 5 µM recombinant FKBP (F36V) or DHFR was added to the media before imaging. For half-life experiments, cells were treated with 25 µM emetine. For E1 inhibitor experiments, cells were treated with 10 µM E1 inhibitor ([@bib11]) for 3 h before shield-1 washout.

FRAP experiments were performed using a confocal microscope (FV-1000; Olympus) containing a CO~2~/temperature incubator (Life Imaging Services). The microscope was equipped with a sim scanner (FV1200; Olympus), which enables simultaneous photobleaching with a 405-nm laser while scanning with a 488-nm laser. All experiments were performed using a 60×/1.35 oil objective. FRAP experiments were performed by exposing a 5-µm region in single cells to 100% laser intensity for 0.45 ms. Imaging was typically performed at 1% laser intensity using the 488-nm laser. The interval between image scans varied depending on the duration of recovery and was either 1 s or 250 ms for slow and fast recovery, respectively. 10 prebleach and 180 postbleach frames were recorded for each series. As cells tended to move during the imaging time, the ImageJ StackReg plugin was used for quantitative analysis. The mean fluorescence intensities of the bleached region for each time point were normalized to the mean of the last five prebleach values. These values were divided by the total cell fluorescence in order to correct for changes in total fluorescence.

Poly-Ub affinity capture {#s12}
------------------------

Stably or transiently transfected cells were harvested with trypsin and PBS, washed twice with PBS, lysed in cold buffer containing 50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, and 1 mM EDTA, pH 7.5, and supplemented with protease inhibitors (Roche) and 5 mg/ml *N*-ethylmaleimide. Lysates were rotated at 4°C for 15 min and cleared by centrifugation at 20,000 *g* for 20 min. 0.5 mg of cleared lysate was diluted fivefold with cold binding buffer containing 10 mM Hepes, 20 mM imidazole, 150 mM NaCl, and 0.5% Triton X-100, pH 7.4, and added to 25 µl Affigel-10 beads (Bio-Rad Laboratories) covalently conjugated to purified hplic2~UBA~ prepared as a 50% slurry in binding buffer. Lysate and beads were incubated overnight at 4°C and washed three times with binding buffer, and bound proteins were eluted by incubating at 65°C for 10 min in 2× SDS loading buffer. Eluted proteins and 2% of unbound fraction were resolved by SDS-PAGE, transferred for 100 min at 95 V to a polyvinylidene difluoride membrane, and immunoblotted with antibodies against Ub (P4G7; Abcam) or GFP (JL-8; Takara Bio Inc.). The membrane was immunoblotted with a secondary goat anti--mouse antibody (IR dye 800; LI-COR Biosciences) and scanned using an imaging system (Odyssey; LI-COR Biosciences).

Flow cytometry {#s13}
--------------

For PulSA flow cytometric analysis, cells were analyzed on a flow cytometer (LSR II; BD) equipped with 488- and 535-nm lasers. U2-Q91 cells were transiently transfected with the indicated GFP constructs and treated with stabilizing ligands or vehicle. The following day, expression of httQ91-mCherry was induced with 1 µg/ml dox, and cells were incubated for an additional 72 h before harvesting and analysis. 20,000--30,000 cells were analyzed in the high GFP gate (Fig. S4 E) for each sample, and measurements for mCherry and GFP peak width, peak height, and total intensity were collected. Flow cytometry analysis software (Flow Jo; Tree Star) was used to subdivide the GFP axis into low and high GFP fluorescence gates (Fig. S4 E). The total mCherry intensity of cells in each GFP gate was subdivided into 41 bins of equal intensity. For analysis of the fraction of cells with IBs by PulSA, cells with IBs were identified using an mCherry peak width versus peak height scatter plot, and a lasso gate was drawn around the IB population. The fraction of cells with IBs was plotted against binned total mCherry fluorescence intensity (Fig. S4 B).

Statistical analysis {#s14}
--------------------

P-values were generated by applying a two-tailed *t* test to pooled data from individual cells for given time points. P-values \>0.05 were reported as nonsignificant. To compare half-life measurements (t~1/2~), decay data for individual cells were fitted to a one-phase exponential decay equation using Prism (GraphPad Software), and p-values for pooled half-life data were generated using a *t* test.

Online supplemental material {#s15}
----------------------------

Fig. S1 shows additional characterization of reporter cell lines and effects of E1 inhibitor on levels of poly-Ub conjugates. Fig. S2 shows half-life of the Ub^G76V^-Venus-DD reporter and the effect of E1 inhibitor on GFP-DD~FKBP~ localization and recruitment of httQ91-mCherry to IBs. Fig. S3 shows additional characterization of U2-Ub-Q91 cells and YFP-Ub FRAP data. Fig. S4 explains the PulSA method and shows control experiments for the PulSA experiments in [Fig. 4](#fig4){ref-type="fig"}. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201511024/DC1>.
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